What Happened?
Needham, MA-based Candel Therapeutics Appointed Sandra Poole as Chief Operating Officer
Date of management change: January 10, 2020
Needham, MA-based Candel Therapeutics Appointed Sandra Poole as Chief Operating Officer
Also known as Advantagene. Inc., we are a Massachusetts-based biotechnology company developing our proprietary immuno-oncology platforms for the treatment of solid tumors, including our Gene Mediated Cytotoxic (GMCI™) platform and our rQNestin34.5 platform. GMCI™ is an "off-the-shelf" immunotherapy designed to generate a personalized, robust, and precise systemic response from the patient's own immune system against his or her cancer.
Sandra Poole is Chief Operating Officer at Candel Therapeutics. Previously, Sandra held various senior IT leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Jaissle Jason, Cook Darren, Silva Eric, Isahack Joseph, O'Neil Kelley, Coleman Brian, Dezell Brian, Bass Brandon, Gibson Scott, Rice Brian, Gichana Doug
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.